Sept 25 (Reuters) – ADARx Pharmaceuticals said on Thursday it had raised $446.3 million in an upsized US initial public offering, reflecting growing investor appetite for biotech listings. The San
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
Gauff beats Kostyuk, awaits Pegula result at WTA Finals
VIDEO SHOWS: HIGHLIGHTS OF COCO GAUFF BEATING MARTA KOSTYUK AT THE WTA FINALS COMPLETE SHOTLIST…
UPDATE 3-World oil market is returning to surplus as Gulf exports recover, IEA says
* Fourth-quarter oil supply to exceed demand by 1.7 million bpd * IEA had previously…
South Korea says Nvidia will keep GPU pledges after Huang's resignation
SEOUL, Nov 13 (Reuters) - South Korea's Science and ICT Minister Bae Kyung-hoon said on Friday…
